Evan J. Lipson, MD, Johns Hopkins Medicine

Evan J. Lipson, MD, discusses the effect of preoperative nivolumab plus relatlimab in resectable non-small cell lung cancer (NSCLC).

Evan J. Lipson, MD, discusses the current treatment landscape in locally advanced, unresectable, or metastatic basal cell carcinoma.

Evan J. Lipson, MD, discusses the role of circulating tumor DNA ​testing in melanoma.